Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ethicon Endo-Surgery (Europe) GmbH
The European prospective observational multi-center cohort study aims to collect real-world outcomes of consecutive patients scheduled for VATS lobectomy for histologically confirmed Non-Small Cell Lung Cancer (NSCLC) or scheduled for VATS wedge resection for undiagnosed pulmonary nodule or metastasis from colorectal cancer (CRC) in accordance with their institution's Standard-of-care (SOC).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed NSCLC (up to and including Stage II) for patients undergoing VATS lobectomy. For patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from CRC, a malignant diagnosis may be confirmed post-operatively.
Scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
Willing to give consent and comply with evaluation and treatment schedule
At least 18 years of age
You may not be if
Active bacterial infection or fungal infection
Systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
Chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
Scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and VATS lymphadenectomy are allowed);
